Over the last several years, a renaissance in psychedelic research has begun to transform the study of human consciousness and its role in mental illness. In randomized clinical trials, psychedelic-assisted therapies have shown promise in the treatment of multiple psychiatric disorders, with both MDMA and psilocybin receiving a “breakthrough therapy” designation from the FDA. This … Read morePsychedelic Medicine Virtual Webinar [ONLINE]
FEATURING: Rick Doblin Founder of Multidisciplinary Association for Psychedelic Studies (MAPS) HOSTED BY: Neil McArthur – University of Manitoba Darek Dawda – Enhanced Therapy Institute DESCRIPTION: This conference will examine in depth ethical, clinical, and legal issues related to MDMA-Assisted Therapy, a new form of therapy that combines psychological treatment and a powerful psychoactive MDMA medication. Promising … Read moreMDMA and Psychedelic Assisted Therapy: Ethics and Law [ONLINE]
Virtual Continuing Education Class With Matthew W. Johnson, Ph.D. & friends. New research suggests that psychedelic-assisted therapy may be an effective treatment for a range of substance abuse disorders, including alcoholism and cigarette smoking. Early research with psychedelic therapy in the 1960s and 1970s showed great promise, and several new psilocybin studies show great potential … Read moreIntroduction to Psychedelic Therapy for Addiction Medicine [ONLINE]
On the Future of Psychedelic Assisted Therapy: A Live Online Conversation with Rick Doblin About this Event Psychedelic assisted psychotherapy is on track to be the next breakthrough in mental health care. The last decade has seen a renaissance in the field of psychedelic science—moving it from the fringes of the scientific world to the … Read moreOn the Future of Psychedelic Assisted Therapy [ONLINE]
Dr. Joe Tafur, MD Episode Summary: For the last two years, Modern Spirit, a nonprofit dedicated to demonstrating the value of spiritual healing in modern healthcare, has been collaborating with MAPS and the USC Department of Psychiatry. Participating study centers have been collecting saliva samples before and after the MDMA-assisted Psychotherapy intervention for PTSD. The … Read moreEpigenetics in Psychedelic-Assisted Therapies: Spiritual Healing in Modern Healthcare [ONLINE]
The Synthesis Institute is hosting Guiding the Unbound Mind: What Every Practitioner Must Know About Working with Psychedelics, an online psychedelic expert forum featuring former Imperial College London Lead Psychedelic Researcher and Clinical Director of The Synthesis Institute, Dr. Rosalind Watts, co-founder of Guild of Guides Netherlands and Lead Facilitator at The Synthesis Institute, Daan Keiman, … Read moreGuiding the Unbound Mind: What Every Practitioner Must Know About Working With Psychedelics [ONLINE]
Virtual CE/CME Continuing Education Class Join psychedelic therapy luminary Bill Richards, Ph.D. and rising researcher Brian D. Richards, Psy.D. for an all-day exploration of the history and potential of psilocybin-assisted psychotherapy.
Virtual CE/CME Continuing Education Class Join MDMA research pioneers Michael Mithoefer, MD and Annie Mithoefer, BSN for an in-depth exploration of the history, present, and future of MDMA-assisted psychotherapy for clinical applications such as treatment of PTSD and depression.
Presenter: Andrew Penn, RN, MS, PMHMP Discussant: Patricia Penn, LCSW, PhD Description: The use of psychedelic medicines such as MDMA and psilocybin as catalysts to psychotherapy has been receiving a lot of press as they advance through clinical trials, which if successful, would lead to FDA approval for the use of these medicines as adjuncts … Read moreGetting Unstuck: the promise of psychedelic assisted therapies [ONLINE]
Measure 109: What It Does. Who It Helps. Pioneering research at America’s top universities shows that psilocybin therapy can help those suffering from depression, anxiety, and addiction. Measure 109 is a carefully crafted ballot initiative supported by medical experts, veterans, and people from over 300 Oregon cities to bring this “breakthrough therapy” to Oregon. More … Read moreA Discussion with Oregon’s Measure 109 Campaign Team [ONLINE]